> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md).
# Ovarian Cancer
Ovarian cancer is one of the strongest translational settings for WFA.
It combines robust preclinical synergy data, direct cancer stem cell relevance, and an active human trial landscape.
### Why ovarian cancer is such a good fit
A central problem in ovarian cancer is persistence of stem-like, treatment-resistant cell populations after chemotherapy. WFA repeatedly looks relevant in exactly that space.
It does not just add generic cytotoxicity. It appears to correct part of the stem-cell enrichment problem that platinum therapy can worsen.
### Cell data
WFA alone and in combination with cisplatin has reduced CSC-enriched populations marked by `CD44`, `CD24`, `CD34`, `CD117`, and `Oct4` in ovarian models.
It also suppresses `Notch1/Hes1/Hey1` signalling, which is closely tied to CSC self-renewal. That matters because cisplatin can move this pathway in the opposite direction.
This makes the combination mechanistically attractive rather than simply additive.
### Animal data
In orthotopic ovarian tumour models, WFA plus cisplatin produced major tumour-growth reduction and strong suppression of metastasis. Work in `ALDH1+` CSC-enriched tumours also showed inhibition of spheroid formation.
A separate line of work suggests WFA may help address ovarian cancer-associated cachexia, including skeletal muscle wasting. That is an unusual additional angle and may matter clinically if it translates.
### Human data
The most advanced current human study is an ovarian cancer trial combining Ashwagandha extract with liposomal doxorubicin.
That is an important translational step, but it still does not provide purified-WFA efficacy data.
### Clinical setting assessment
Ovarian cancer is likely the most clinically advanced WFA setting right now.
The reason is not only the active trial. It is also the underlying biology. CSC depletion, platinum resistance relevance, and metastasis control all fit the disease well.
### Bottom line
Ovarian cancer is one of the strongest near-term areas to watch for clinically meaningful WFA translation.
### Key references
Kakar S. et al. — ovarian-cancer cisplatin synergy and cancer stem cell depletion in vivo.\
Mukherjee A. et al. — ovarian-cancer cachexia and muscle-wasting relevance.\
University of Louisville recurrent ovarian cancer trial listing.\
Access and availability:\
Source: MCS Formulas, “Withaferin A Pro Liposomal.”\
`50 mg` WFA per capsule. Available via healthcare professional request.\
### In this section
#### Core pages
* [Withaferin A (WFA) in Oncology](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology.md)
* [Evidence Summary](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/evidence-summary.md)
* [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/anti-cancer-mechanisms.md)
* [Immune Effects](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/immune-effects.md)
* [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/synergistic-combinations.md)
#### Cancer-type pages
* [WFA Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type.md)
* [Breast Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/breast-cancer.md)
* [Ovarian Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md)
* [Non-Small Cell Lung Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/non-small-cell-lung-cancer.md)
* [Glioblastoma](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/glioblastoma.md)
* [Other Cancer Types](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/other-cancer-types.md)
#### Practical pages
* [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/pharmacokinetics-and-metabolism.md)
* [Sourcing Quality](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md)
* [Safety, Interactions and WFA Dosing](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/safety-interactions-and-wfa-dosing.md)
* [Hormones — ER-α and Androgens](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/hormones-er-a-and-androgens.md)
* [Terrain Support — Liposomal WFA vs Whole-Plant Ashwagandha](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/terrain-support-liposomal-wfa-vs-whole-plant-ashwagandha.md)
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.